Glutathione-conferred resistance to antineoplastics: Approaches toward its reduction
Authors:
- Susan Somfai-RelleSSSusan Somfai-Relle
- Kayoko SuzukakeKSKayoko Suzukake
- Barbara P. VisticaBVBarbara P. Vistica
- David T. VisticaDVDavid T. Vistica
- 1 March 1984
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 11, 43-54
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Reduction in cellular glutathione by buthionine sulfbximine and sensitization of murine tumor cells resistant to L-phenylalanine mustardBiochemical Pharmacology, 1984
- Dechlorination of l-phenylalanine mustard by sensitive and resistant tumor cells and its relationship to intracellular glutathione contentBiochemical Pharmacology, 1983
- Reduction in glutathione content of L-PAM resistant L1210 cells confers drug sensitivityBiochemical Pharmacology, 1982
- Cytotoxicity as an indicator for transport mechanism: evidence that murine bone marrow progenitor cells lack a high-affinity leucine carrier that transports melphalan in murine L1210 leukemia cellsBlood, 1980
- Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridineAnalytical Biochemistry, 1980
- Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).Journal of Biological Chemistry, 1979
- Chemotherapy of advanced ovarian carcinoma: A prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideGynecologic Oncology, 1974
- The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y)Biochemical Pharmacology, 1968
- Amino Acid Diets and Maximal Growth in the RatThe Journal of Nutrition, 1965
- Tumour sulphydryl levels and sensitivity to the nitrogen mustard merophanBiochemical Pharmacology, 1963